Candidemia at a tertiary-care hospital:: Epidemiology, treatment, clinical outcome and risk factors for death

被引:196
作者
Viudes, A
Pemán, J
Cantón, E
Ubeda, P
López-Ribot, JL
Gobernado, M
机构
[1] Hosp Univ La Fe, Microbiol Serv, Valencia 46009, Spain
[2] Hosp Univ La Fe, Unidad Bacteriol Expt, Valencia, Spain
[3] Univ Texas, Hlth Sci Ctr, Dept Med, Div Infect Dis, San Antonio, TX 78284 USA
关键词
D O I
10.1007/s10096-002-0822-1
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The demographic, clinical and microbiological data of patients with candidemia at the "Hopital Universitario La Fe", a tertiary-care hospital in Valencia, Spain, from 1995 to 1997 was analyzed retrospectively. Candida spp. were isolated in blood cultures from 145 patients, 32% of whom were children (25% of these were neonates). The most common species isolated was Candida albicans, followed by Candida parapsilosis, Candida krusei and Candida tropicalis. Risk factors for candidemia included underlying disease, therapy with broad-spectrum antibiotics and the presence of a central venous catheter. The majority of children were treated with amphotericin B, whereas 52% of adults received fluconazole. Overall mortality was 44% (30% in children and 50% in adults), and attributable mortality was 30% (24% in children and 33% in adults). Multivariate analysis indicated that neutropenia, corticosteroid therapy, lack of antifungal treatment, and failure to replace the central venous catheter were factors associated with candidemia-related death. Among the adult population, an APACHE II score greater than 15 predicted candidemia-related death.
引用
收藏
页码:767 / 774
页数:8
相关论文
共 73 条
[1]   Candida krusei fungemia -: An escalating serious infection in immunocompromised patients [J].
Abbas, J ;
Bodey, GP ;
Hanna, HA ;
Mardani, M ;
Girgawy, E ;
Abi-Said, D ;
Whimbey, E ;
Hachem, R ;
Raad, I .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (17) :2659-2664
[2]   The epidemiology of hematogenous candidiasis caused by different Candida species [J].
AbiSaid, D ;
Anaissie, E ;
Uzun, O ;
Raad, I ;
Pinzcowski, H ;
Vartivarian, S .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (06) :1122-1128
[3]   Predictors of adverse outcome in cancer patients with candidemia [J].
Anaissie, EJ ;
Rex, JH ;
Uzun, Ö ;
Vartivarian, S .
AMERICAN JOURNAL OF MEDICINE, 1998, 104 (03) :238-245
[4]  
BALEY JE, 1984, PEDIATRICS, V73, P153
[5]   NEONATAL CANDIDIASIS - THE CURRENT CHALLENGE [J].
BALEY, JE .
CLINICS IN PERINATOLOGY, 1991, 18 (02) :263-280
[6]   SECULAR TRENDS IN NOSOCOMIAL PRIMARY BLOOD-STREAM INFECTIONS IN THE UNITED-STATES, 1980-1989 [J].
BANERJEE, SN ;
EMORI, TG ;
CULVER, DH ;
GAYNES, RP ;
JARVIS, WR ;
HORAN, T ;
EDWARDS, JR ;
TOLSON, J ;
HENDERSON, T ;
MARTONE, WJ .
AMERICAN JOURNAL OF MEDICINE, 1991, 91 :S86-S89
[7]  
BECKSAGUE CM, 1993, J INFECT DIS, V167, P1247, DOI 10.1093/infdis/167.5.1247
[8]   Risk factors for candidal bloodstream infections in surgical intensive care unit patients: The NEMIS Prospective Multicenter Study [J].
Blumberg, HM ;
Jarvis, WR ;
Soucie, JM ;
Edwards, JE ;
Patterson, JE ;
Pfaller, MA ;
Rangel-Frausto, MS ;
Rinaldi, MG ;
Saiman, L ;
Wiblin, RT ;
Wenzel, RP .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (02) :177-186
[9]  
Canton Emilia, 2001, Revista Iberoamericana de Micologia, V18, P51
[10]  
Chakrabarti A, 1996, INDIAN J MED RES, V104, P171